Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Kaidre Bendjama, Transgene, Strasborg, France, outlines the current activities of Transgene, a biotechnology company that designs and develops innovative immunotherapies, including personalized therapeutic vaccines and multifunctional oncolytic viruses. This interview took place at the virtual American Association for Cancer Research (AACR) Annual Meeting 2021.
Disclosures
Kaidre Bendjama is a full-time employee of Transgene SA.
We use cookies to provide the best experience on our website. We also use third party cookies to collect analytical data and better improve our marketing strategies. If you continue to use this site you are consenting to the use of these cookies. For more information view our Cookie Policy.